ESC 365
Menu
Home
Search
Live & Upcoming Events
About
Create an account
Sign in
Back
ESC Premium Access
Potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Event:
ESC CONGRESS 2016
Topic:
Thrombosis and platelets
Session type:
Satellite Symposium
Sponsored by Daiichi Sankyo Europe GmbH
Date:
28 August 2016
Time:
12:45 - 13:45
Session
0
4
presentations
in this session
Welcome & introduction: Potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Speaker:
Professor K. Huber (Vienna, AT)
Access
1
How to apply guidelines to clinical practice.
Speaker:
Professor A. Schaefer (Hannover, DE)
Access
0
Optimising P2Y12 inhibition in real world clinical practice: clinical outcomes of prasugrel and ticagrelor.
Speaker:
Professor J. Jukema (Leiden, NL)
Access
0
Discussion – Summary and closing remarks: potent P2Y12 receptor inhibition – What can we learn from clinical practice?
Speaker:
Professor K. Huber (Vienna, AT)
Access
0
4
speakers
from this session
Professor Kurt Huber
Wilhelminen Hospital, Vienna (Austria)
40
presentations
6
followers
Professor Andreas Schaefer
Hannover Medical School, Hannover (Germany)
5
presentations
0
follower
Professor J Wouter Jukema
Leiden University Medical Centre, Leiden (Netherlands (The))
14
presentations
0
follower
Professor Kurt Huber
Wilhelminen Hospital, Vienna (Austria)
40
presentations
6
followers
This platform is supported by